TRPM6 (Transient Receptor Potential Melastatin 6) is a unique member of the TRP (Transient Receptor Potential) channel family characterized by its dual function as an ion channel and a protein kinase. It serves as the primary pathway for magnesium (Mg²⁺) absorption in the intestinal epithelium and plays a critical role in renal magnesium reabsorption. While direct evidence linking TRPM6 to neurodegenerative diseases remains limited, magnesium homeostasis is increasingly recognized as a crucial factor in neuronal function, synaptic plasticity, and neuroprotection—all processes central to Alzheimer's disease (AD) and Parkinson's disease (PD) pathogenesis.
The TRPM6 gene (located on chromosome 9q21.13 in humans) encodes a protein of 2,028 amino acids with a molecular weight of approximately 230 kDa. TRPM6 is a member of the melastatin subfamily of TRP channels, which includes its closest paralog TRPM7 — a channel-kinase with overlapping functional properties.
TRPM6 possesses several distinctive structural domains:
The protein forms functional homomers or heteromers with TRPM7 to create calcium (Ca²⁺)-permeable, magnesium-sensitive ion channels. [1]
TRPM6 is predominantly expressed in:
The relatively limited expression pattern in the brain, compared to TRPM7 which is widely expressed in neurons and glia, may explain the weaker direct link between TRPM6 and neurodegenerative processes. However, systemic magnesium deficiency can profoundly affect neuronal function regardless of local TRPM6 expression. [2]
TRPM6 is the principal channel mediating active magnesium absorption in the gastrointestinal tract. Magnesium homeostasis is essential for numerous cellular processes, including:
Intestinal magnesium absorption occurs via both paracellular (passive) and transcellular (active) pathways. TRPM6 becomes particularly important when dietary magnesium intake is low, representing the regulated, saturable component of absorption. The channel is activated by low intracellular Mg²⁺ concentrations and by the dietary peptide sphingosine-1-phosphate. [3]
Approximately 80% of filtered magnesium is reabsorbed in the thick ascending limb of the loop of Henle via the paracellular pathway, while the remaining 20% is reabsorbed in the distal convoluted tubule (DCT) through active transcellular transport—primarily mediated by TRPM6. The DCT is the final and rate-limiting segment for magnesium conservation, making TRPM6 essential for maintaining magnesium balance. [4]
TRPM6 can form heteromeric channels with TRPM7, creating channels with intermediate properties. TRPM7 is more broadly expressed, including in:
This broader expression pattern makes TRPM7 more directly relevant to neuroprotection, though both channels contribute to cellular magnesium homeostasis. [5]
Biallelic loss-of-function mutations in TRPM6 cause autosomal recessive familial hypomagnesemia with secondary hypocalcemia (HSH; OMIM #602014). This rare disorder is characterized by:
The neurological symptoms in HSH directly demonstrate the critical importance of magnesium for neuronal function. Seizures and ataxia result from magnesium's role in stabilizing neuronal membranes and regulating excitatory synaptic transmission. [6]
Multiple epidemiological studies have examined the relationship between magnesium status and cognitive function:
Alzheimer's Disease: Several studies have found reduced serum magnesium levels in AD patients compared to age-matched controls. Magnesium acts as a natural NMDA receptor antagonist, and deficient magnesium homeostasis may contribute to excitotoxicity—a key mechanism in AD neurodegeneration. Furthermore, magnesium is required for synaptic plasticity and long-term potentiation, processes critical for memory formation. [7]
Parkinson's Disease: Studies have shown that PD patients often have lower cerebrospinal fluid (CSF) magnesium levels than healthy controls. Magnesium exerts neuroprotective effects by:
Population Studies: A large prospective study found that higher dietary magnesium intake was associated with reduced risk of incident dementia, suggesting a potential protective role for magnesium against neurodegenerative processes. [9]
Given the role of TRPM6 in systemic magnesium homeostasis, pharmacological activation of TRPM6 represents a therapeutic strategy for:
While oral magnesium supplementation is commonly used, the efficacy depends on intestinal absorption, which declines with age. TRPM6 activity becomes particularly important in:
The relationship between systemic magnesium status and neuronal function underscores the potential importance of TRPM6 function—even without direct neuronal expression—for brain health. [10]
While TRPM6 has limited direct neuronal expression, TRPM7 is widely expressed in the nervous system and has been more directly implicated in neurodegeneration:
The distinction between TRPM6 and TRPM7 is crucial for understanding their respective roles in neurodegeneration. [5:1]
Magnesium homeostasis interacts with multiple pathological processes relevant to neurodegeneration:
'Huang Y, et al'. Structure of the TRPM6 transmembrane segment pore and its activation mechanism. Cell Rep. 2022. ↩︎
'Yamanaka R, et al'. Magnesium homeostasis in neurons and glial cells. Neurochem Res. 2014. ↩︎
'Hoenderop JG, et al'. Molecular mechanisms of active magnesium absorption in the intestine. J Am Soc Nephrol. 2005. ↩︎
'Nair AV, et al'. Magnesium reabsorption in the distal convoluted tubule. Kidney Int. 2021. ↩︎
'Wang H, et al'. TRPM7 in neurodegenerative diseases: A potential therapeutic target. Front Cell Neurosci. 2023. ↩︎ ↩︎
'Clapham DE, et al'. TRPM6 and TRPM7: Channelopathies and beyond. Neuron. 2003. ↩︎
'V一项 ET al'. Magnesium and Alzheimer's disease. Nutrients. 2022. ↩︎
'Shen L, et al'. Magnesium and Parkinson's disease: A review. Front Aging Neurosci. 2023. ↩︎
'Zhang Y, et al'. Dietary magnesium intake and risk of incident dementia. Neurology. 2022. ↩︎
'Baran A, et al'. Magnesium and cognitive function: A systematic review. Nutrients. 2023. ↩︎